03-04-2025
Blue Owl Capital Inc. to Announce First Quarter 2025 Results
NEW YORK, April 3, 2025 /PRNewswire/ -- Blue Owl Capital Inc. (NYSE: OWL) ("Blue Owl") today announced it will release its financial results for the first quarter ended March 31, 2025 on Thursday, May 1, 2025 before market open. Blue Owl invites all interested persons to its webcast / conference call at 10 a.m. Eastern Time to discuss its results.
Conference Call Information:
The conference call will be broadcast live on the Shareholders section of Blue Owl's website at
Participants are also invited to access the conference call by dialing one of the following numbers:
Domestic (Toll Free): +1 (888) 330-2454
International: +1 (240) 789-2714
Conference ID: 4153114
All callers will need to enter the Conference ID followed by the # sign and reference "Blue Owl Capital" once connected with the operator. All callers are asked to dial in 10-15 minutes prior to the call so that name and company information can be collected.
Replay Information:
An archived replay will be available via a webcast link located on the Shareholders section of Blue Owl's website.
About Blue Owl Capital Inc.
Blue Owl (NYSE: OWL) is a leading asset manager that is redefining alternatives®.
With over $250 billion in assets under management as of December 31, 2024, we invest across three multi-strategy platforms: Credit, GP Strategic Capital, and Real Assets. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer institutional investors, individual investors, and insurance companies differentiated alternative investment opportunities that aim to deliver strong performance, risk-adjusted returns, and capital preservation.
Together with over 1,100 experienced professionals globally, Blue Owl brings the vision and discipline to create the exceptional. To learn more, visit
Investor ContactAnn DaiHead of Investor Relationsblueowlir@
Media ContactNick TheccanatPrincipal, Corporate Communications & Government
View original content:
SOURCE Blue Owl Capital
